Press release
AI-Enabled Drug Discovery and Clinical Trials Market Report Latest Trends and Future Opportunities Analysis
The AI-Enabled Drug Discovery and Clinical Trials Market Size is valued at USD 706.90 Million in 2023 and is predicted to reach USD 4643.75 Million by the year 2031 at a 26.65 % CAGR during the forecast period for 2024-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1239
AI-Enabled Drug Discovery and Clinical Trials are fundamental procedures primarily done by using artificial intelligence technology that has been gaining wide acceptance across the world. Increasing penetration of technology in the healthcare industry will further boost AI-Enabled Drug Discovery and Clinical Trials market potential in the long run. Digitization of the healthcare industry saw a significant boost in the COVID-19 pandemic, and this trend has created a lucrative setting for AI-Enabled Drug Discovery and Clinical Trials market growth throughout the forecast period. Increasing support from the government and rising demand for rapid development of drugs is expected to boost AI-Enabled Drug Discovery and Clinical Trials market potential.
Human rights concerns associated with clinical trials are also a factor that increases the adoption of AI in clinical trials and drug discovery as they reduce the risk to human health. However, the high costs of deployment and operation of AI-Enabled Drug Discovery and Clinical Trials are projected to have a hampering effect on the global AI-Enabled Drug Discovery and Clinical Trials market potential through 2030. The rising establishment of multiple healthcare research companies will also favour AI-Enabled Drug Discovery and Clinical Trials market potential throughout the forecast period.
List of Prominent Players in the AI-Enabled Drug Discovery and Clinical Trials Market:
Accutar Biotechnology Inc.
AiCure
Ardigen
Atomwise Inc.
Benevolent AI
Berg
Berkeley Lights
BioAge Labs
Biovista
C4X Discovery Holdings Plc
Clinithink Ltd
Cloud Pharmaceuticals
Cyclica Inc.
CytoReason
Concerto Health AI.
Deep Genomics Inc.
DeepThink Health Inc.
Envisagenics, Inc.
Exscientia Limited
e-therapeutics plc
GNS Healthcare
Insilico Medicine
Lantern Pharma Inc.
Medable, Inc.
Mind the Byte
NuMedii, Inc
Nuritas, Ltd.
Owkin, Inc.
Recursion Pharmaceuticals, Inc.
Schrödinger, LLC
Symphony Innovation, LLC
TARA Biosystems, Inc.
twoXAR, Incorporated
Verge Analytics, Inc.
Winterlight Labs Inc.
WuXi Nextcode Genomics
XtalPi Inc.
Other Prominent Players
Order this Premium Report: https://www.insightaceanalytic.com/buy-report/1239
Market Dynamics:
Drivers:
The increasing prevalence of chronic diseases and augmented demand for better healthcare services is expected to drive AI-Enabled Drug Discovery and Clinical Trials market growth. Other factors such as increasing incidence of chronic diseases, rising research activity, growing support from the government, high healthcare expenditure, etc., are also expected to crucially sculpt AI-Enabled Drug Discovery and Clinical Trials market growth over the forecast period. The increasing digitization of the healthcare industry is also expected to drive AI-Enabled Drug Discovery and Clinical Trials market growth in the coming years.
Challenges:
The major challenge for AI-Enabled Drug Discovery and Clinical Trials market is to manage the deployment and operations cost of these new systems that will be very complex to use and maintain. The absence of a skilled workforce for the same is also anticipated to hinder the adoption of AI-Enabled Drug Discovery and Clinical Trials systems across the world. The companies in the AI-Enabled Drug Discovery and Clinical Trials market are expected to work on these challenges to unlock full growth potential over the coming years.
Regional Trends:
North America holds a considerable proportion of the global market for AI-Enabled Drug Discovery and Clinical Trials due to its quick adoption of innovative technology. This region's market potential for AI-Enabled Drug Discovery and Clinical Trials will be driven through 2030 by the presence of developed healthcare infrastructure, a high level of healthcare research activity, and supporting government efforts. The United States is likely to be a very lucrative market in this area due to the increasing frequency of cancer and the necessity for earlier treatment. Additionally, high healthcare expenditures will play a significant function in this industry. The ageing population will also fuel the market potential for AI-Enabled Drug Discovery and Clinical Trials in the next years.
Recent Developments:
In May 2022, Standigm announced that it would be eyeing using its expertise to find a treatment for Crohn's disease. With the help of AI, the company plans to produce new compounds to test for their treatment effects on multiple patients.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1239
AI-Enabled Drug Discovery and Clinical Trials Market Segmentation:
AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By Component Estimates & Trend Analysis
• Solutions
• Services
AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By Application Estimates & Trend Analysis
• Data Aggregation and Analysis
• Clinical Trials
• Drug Design
• Drug Characterization
• Biomarker Research
AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By Therapeutic Application Estimates & Trend Analysis
• Oncology
• Cardiovascular Diseases
• Nervous System Diseases
• Respiratory Disorder
• Metabolic Diseases
• Immunologic Diseases
• Infectious Diseases
AI-Enabled Drug Discovery and Clinical Trials Market Segmentation: By End-user Estimates & Trend Analysis
• Biopharmaceutical Industry
• Contract Research Organizations (CROs)
• Academic Institutes and Research Centers
Details insights on this market: https://www.insightaceanalytic.com/report/global-ai-enabled-drug-discovery-and-clinical-trials-market-/1239
Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email : info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact US:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release AI-Enabled Drug Discovery and Clinical Trials Market Report Latest Trends and Future Opportunities Analysis here
News-ID: 3509943 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
